Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.21 USD | -9.02% | -11.68% | -2.42% |
05-09 | Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.42% | 253M | |
+3.91% | 109B | |
+10.87% | 105B | |
-0.26% | 22.25B | |
-13.14% | 22.09B | |
-8.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- AKBA Stock
- News Akebia Therapeutics, Inc.
- Piper Sandler Downgrades Akebia Therapeutics to Neutral From Overweight, Adjusts Price Target to $2 From $8